期刊文献+

351例涂阳肺结核患者的发现与治疗转归分析

351 smear positive pulmonary tuberculosis patients found and treatment outcome analysis
原文传递
导出
摘要 目的了解某地肺结核患病情况和治疗转归,以提高涂阳肺结核患者的发现率和治愈率。方法根据阿克陶县2010-2014年肺结核患者登记表、季报表和年报表,对涂阳肺结核患者发现和治疗转归情况进行分析。结果 2010-2014年共登记涂阳肺结核患者351例,其中初治涂阳248例,复治涂阳103例。平均涂阳患者登记率为338.14/10万,初治涂阳与复治涂阳治愈率分别为88.31%和75.73%。结论 5年以来,新疆阿克陶县结核病防治工作虽然取得了一定的成绩,但是涂阳肺结核病疫情仍然很重,复治涂阳肺结核患者的治愈率较低。需要加强涂阳肺结核患者的发现及全程督导管理治疗,提高治愈率,降低结核病疫情。 Objective To learn the prevalence of tuberculosis and the treatment outcomes in a certain area, for improving the detection and cure rates of the smear positive tuberculosis patients. Methods The conditions of detection and treatment outcomes of the smear positive tuberculosis patients were analyzed according to the records of tuberculosis patients between 2010 and 2014 in Akto, xinjiang. Results 351 smear positive tuberculosis patients were recorded between 2010 and 2014. 248 of them were initially detected and 103 were recruitable detected. The average registration rate of the smear positive tuberculosis patients was 338.14 patients/100 000 population. The recovery rates of initially detected smear positive pulmonary tuberculosis and recruitable detected smear positive pulmonary tuberculosis patients were 88.31% and 75.73%, respectively. Conclusion The recovery rate of recruitable detected smear positive pulmonary tuberculosis patients was relatively low, and the tuberculosis epidemic was still serious in last 5 years in Akto, Xinjiang. The effective measures for control of prevalence of tuberculosis such as detection smear of positive and full duration management and treatment to tuberculosis patients were needed.
出处 《中国城乡企业卫生》 2016年第8期87-89,共3页 Chinese Journal of Urban and Rural Enterprise Hygiene
关键词 肺结核 控制 新疆阿克陶县 Tuberculosis Control Akto.xinjiang
  • 相关文献

参考文献5

二级参考文献33

  • 1刘博,任家顺,周峰,尚进,黄坚,温悦,张沁宏,练燕,胡婧.全过程质量管理体系在药品监管中的应用[J].西南国防医药,2010,20(6):659-661. 被引量:5
  • 2徐广保,刘飞鹰,董柏青.广西初、复治涂阳肺结核病人治疗转归队例分析[J].广西医学,2006,28(12):1921-1923. 被引量:2
  • 3卫生部疾病预防控制局,卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版)[M].北京:中国协和医科大学出版社,2009:14-18.
  • 4中华人民共和国卫生部疾病预防控制局,中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版).北京:中国协和医科大学出版社,2009:53.
  • 5赖钰基,王林,王倪,徐敏,刘剑君,成诗明,马士文,李仁忠,Vim Dias,Antonio Campopiano.河南省和山东省抗结核药品管理评价[J].中国药房,2007,18(25):1929-1932. 被引量:7
  • 6王金花,杨年忠.378例涂阳肺结核临床疗效分析[J].临床肺科杂志,2007,12(10):1059-1060. 被引量:7
  • 7全国第五次结核病流行病学抽样调查技术指导组,全国第五次结核病流行病学抽样调查办公室.全国第五次结核病流行病学抽样调查报告.中国防痨杂志,2012,34(8):485-508.
  • 8Claxton AJ,Cramer J,Pierce C.A systematic review of theassociations between dose regimens and medication compli-ance.Clin Ther,2001,23(8):1296-1310.
  • 9Chiang CY,Bai KJ,Lee CN,et al.Inconsistent dosing ofanti-tuberculosis drugs in Taipei,Taiwan.Int J Tuberc LungDis,14(7):878-883.
  • 10王黎霞,陈明亭.抗结核药品管理手册.2版.北京:人民军医出版社,2011:19-25.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部